Approvals/TGA/PROMETAX PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet

Approved

STANDARD

PROMETAX PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet

Approval Id: b2053d4cd4e2d8a1
Product Name: PROMETAX PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet
Artg Id: 222605
Artg Name: PROMETAX PATCH 15 rivastigmine 13.3mg/24 hours transdermal drug delivery system sachet
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2015-04-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b2053d4cd4e2d8a1

Type

Standard